Alkermes and Eli Lilly are competing for market share in the narcolepsy drug space, utilizing research from Stanford University.
1 report, 1 independent
Updated Sep 13
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Alkermes and Eli Lilly are competing for market share in the narcolepsy drug space, utilizing research from Stanford University.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Alkermes
company
Nothing else this week.
-
Eli Lilly and Company
American pharmaceutical company
-
Stanford University
private research university in Stanford, California, USA